# Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

> **NCT05526443** · — · RECRUITING · sponsor: **Medical University of Graz** · enrollment: 1500 (estimated)

## Conditions studied

- Pancreatic Cancer
- Advanced Pancreatic Carcinoma

## Interventions

- **DRUG:** all approved chemotherapeutic agents from second line

## Key facts

- **NCT ID:** NCT05526443
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-13
- **Primary completion:** 2027-03
- **Final completion:** 2027-09
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526443, "Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05526443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*